HMGB1 and Parkinson disease: These results are consistent with another study showing that intravenous injection of anti-HMGB1 monoclonal antibodies (mAbs) in a rat PD model significantly inhibited microglial activation and reduced the loss of dopaminergic neurons in SNpc (33).